EUCAST News
Here you can find the latest news and updates from EUCAST.
Consultation (14 May - 15 June, extended to 15 July) on revised breakpoints for IV fosfomycin
EUCAST posted a general consultation on revised breakpoints for intravenous fosfomycin. Consultation period 14 May - 15 June, 2022. Revised breakpoints will be published in breakpoint table 2023.[more]
Consultation on the availability of piperacillin and ticarcillin without inhibitors.
EUCAST is considering removing breakpoints for piperacillin without tazobactam and/or ticarcillin without clavulanic acid but only if these agents are no longer used. If you in your country are still using either or both of...[more]
A new version of the QC table for testing of antifungal agents is available
A new version of the QC table for testing of antifungal agents is available on the website. [more]
Cefiderocol Rationale Document updated
The Cefiderocol Rational Document has been revised. Link. [more]
RAST updated to include incubation beyond 8 hours
EUCAST Rapid AST directly from positive blood culture bottles, previously restricted to 4, 6 or 8 hour incubation, has now been validated for 16 - 20 h incubation with specific reading guidelines and interpretive criteria. This...[more]
Guidance note on topical agents revised
Minor revision of the EUCAST Guidance on topical agents[more]
How to: ECOFFs—the why, the how, and the don'ts of EUCAST epidemiological cutoff values. CMI 2022.
How to: ECOFFs—the why, the how, and the don'ts of EUCAST epidemiological cutoff values Identifying the MIC wild-type distribution and its delineation of species targeted for receiving antimicrobial agent breakpoints is an...[more]
